VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine.
Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine. Biol Blood Marrow Transplant. 2008 Nov; 14(11):1298-304.
View in:
PubMed
subject areas
Adolescent
Alemtuzumab
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Neoplasm
Antineoplastic Agents
Child
Child, Preschool
Disease-Free Survival
Female
Follow-Up Studies
Graft Rejection
Graft vs Host Disease
Hematologic Neoplasms
Hematopoietic Stem Cell Transplantation
Humans
Infant
Living Donors
Lymphocyte Transfusion
Male
Metabolic Diseases
Prospective Studies
Retrospective Studies
Severe Combined Immunodeficiency
Survival Rate
Transplantation Chimera
Transplantation Conditioning
Vidarabine
authors with profiles
HELEN HESLOP
NABIL AHMED
MALCOLM BRENNER
ROBERT KRANCE
STEPHEN GOTTSCHALK
GEORGE CARRUM